文献速递运动医学关节外科

无发育不良患者初次髋关节镜治疗股骨髋臼撞击综合征中行关节囊修复的长期生存率与结局

Long-term Survivorship and Outcomes of Patients Without Dysplasia Undergoing Capsular Repair During Primary Hip Arthroscopy for Femoroacetabular Impingement Syndrome.
PubMed 文献 · Am J Sports Med · 2024-06-03

该队列研究前瞻性收集并回顾性分析2008年10月至2011年2月期间接受初次髋关节镜关节囊修复的股骨髋臼撞击综合征患者,至少10年随访时生存率为91%,患者报告结局显著改善,在关节置换风险最高的患者中,关节囊修复组显示出更高生存率的趋势。

要点

  • 初次髋关节镜关节囊修复后10年生存率为91%。
  • 患者报告结局(mHHS、NAHS、HOS-SSS、VAS)显著改善(P < .001)。
  • 关节囊未修复组转为关节置换的比值比为2.54(95% CI,0.873-7.37;P = .087),未达统计学显著。

核心结论

  • 初次髋关节镜关节囊修复患者至少10年随访生存率高,为91%。
  • 未转为关节置换的患者报告结局获得有利改善并达到高临床获益率。
  • 在关节置换风险最高的患者中,关节囊修复观察到更高生存率的趋势。

研究设计与样本

  • 队列研究,证据等级3。
  • 前瞻性收集并回顾性审查2008年10月至2011年2月期间接受初次髋关节镜关节囊修复的患者数据。
  • 纳入至少10年随访且拥有改良Harris髋关节评分(mHHS)、非关节炎髋关节评分(NAHS)和疼痛视觉模拟量表(VAS)评分的患者。
  • 排除同侧髋关节手术、工伤补偿、Tönnis骨关节炎分级>1级和髋关节发育不良(外侧中心边缘角<25°)的患者。
  • 对关节置换风险最高的患者进行倾向性匹配亚组分析,比较关节囊修复与未修复患者。

主要发现

  • 180个合格髋(165例患者)中145个髋(130例患者)获得至少10年随访(80.6%)。
  • 126个髋(86.9%)属于女性,19个髋(13.1%)属于男性。
  • 患者平均年龄为30.3 ± 12.9岁。
  • 10年随访时生存率为91%。
  • 队列在mHHS、NAHS、HOS-SSS和疼痛VAS评分上均显著改善(P < .001)。

关键数值与推荐

  • 队列达到mHHS的患者可接受症状状态(PASS)率为89.8%。
  • 队列达到mHHS的最小临床重要差异(MCID)率为82.4%。
  • 队列达到疼痛VAS的MCID率为80.6%。
  • 倾向性匹配亚组分析中,29个关节囊修复髋与81个关节囊未修复髋匹配。
  • 两组所有患者报告结局均显著改善(P < .05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is a paucity of literature evaluating long-term outcomes and survivorship of patients undergoing primary hip arthroscopy with capsular repair for femoroacetabular impingement syndrome (FAIS). PURPOSE: To report 10-year survivorship and patient-reported outcomes (PROs) after primary hip arthroscopy with capsular repair for FAIS and evaluate the effect of capsular repair in patients at the highest risk for conversion to arthroplasty. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Data were prospectively collected and retrospectively reviewed on all patients undergoing primary hip arthroscopy with capsular repair between October 2008 and February 2011. Patients with a minimum 10-year follow-up on the modified Harris Hip Score (mHHS), Nonarthritic Hip Score (NAHS), and visual analog scale for pain (VAS) scores were selected. The preoperative and minimum 10-year follow-up Hip Outcome Score-Sports Specific Subscale (HOS-SSS) scores were also reported, if available. Patients with ipsilateral hip surgery, worker's compensation, Tönnis osteoarthritis grade >1, and hip dysplasia (lateral center-edge angle <25°) were excluded. Survivorship, PROS, and clinical benefit-minimal clinically important difference (MCID) and Patient Acceptable Symptom State (PASS)-were reported. An additional propensity-matched subanalysis was performed on patients at the highest risk for conversion to arthroplasty, comparing patients undergoing capsular repair to patients with unrepaired capsules. RESULTS: A total of 145 (n = 130 patients) out of 180 eligible hips (n = 165 patients) had a minimum 10-year follow-up (80.6%). Also, 126 hips (86.9%) belonged to women, and 19 hips (13.1%) belonged to men. The mean patient age was 30.3 ± 12.9 years. The survivorship rate was 91% at the 10-year follow-up. The cohort experienced significant improvements (P < .001) in the mHHS, NAHS, HOS-SSS, and VAS for pain scores. Moreover, the cohort achieved high rates of the PASS for the mHHS (89.8%), high rates of the MCID for the mHHS (82.4%), and high rates of the MCID for VAS for pain (80.6%) scores. In the propensity-matched subanalysis performed on patients with the highest risk for arthroplasty, 29 hips with capsular repair were matched to 81 hips with unrepaired capsules. While both groups experienced significant improvements in all PROs (P < .05), the group without capsule repair trended toward a higher conversion to arthroplasty rate when compared with the repair group. In addition, an odds ratio was calculated for the likelihood of converting to arthroplasty after having an unrepaired capsule compared with capsular repair (2.54 [95% CI, 0.873-7.37]; P = .087). CONCLUSION: Patients undergoing primary hip arthroscopy with capsular repair experienced a high survivorship rate of 91% at a minimum 10-year follow-up. Patients who did not convert to arthroplasty saw favorable improvements in PROs and achieved high clinical benefit rates. In addition, among those patients at the highest risk for conversion to arthroplasty, a trend toward greater survivorship was observed with capsular repair.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Domb BG, Lee MS, Owens JS, et al. Long-term Survivorship and Outcomes of Patients Without Dysplasia Undergoing Capsular Repair During Primary Hip Arthroscopy for Femoroacetabular Impingement Syndrome. Am J Sports Med. 2024. PMID: 38828912. doi:10.1177/03635465241248603

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。